Cardiology
News
New guidance on management of acute CVD during COVID-19
Expert guidance comes from Chinese cardiology and infectious disease specialists on how to manage severe emergent cardiovascular disease during...
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.
News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
News
Wuhan data link COVID-19 with myocardial damage
News
COVID-19 shifts telehealth to the center of cardiology
A series of recent mandates aimed at addressing barriers to telehealth ‘have come in a time of desperation,’ one New York–based cardiologist says...
News
Dramatic rise in hypertension-related deaths in the United States
The ‘alarming’ increase in hypertension-related deaths between 2007 and 2017, was particularly prominent in the rural South.
News
AFib-related cardiovascular deaths on the rise
PHOENIX, ARIZ. – A more pronounced increase in mortality rate was observed among black and white men.
News
COVID-19 will test medical supply stocks
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr....
News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2...